AUTL(AUTL)
AUTL
ANALYST COVERAGE14 analysts
BUY
▲ +386.3%upside to target
L $7.60
Med $8.00consensus
H $11.00Key MetricsTTM
Market Cap$437.81M
Revenue TTM$92.59M
Net Income TTM-$288.83M
Free Cash Flow-$291.52M
Gross Margin-11.2%
Operating Margin-285.9%
Net Margin-312.0%
Return on Equity-128.5%
Return on Assets-54.8%
Debt / Equity0.73
Current Ratio5.80
EPS TTM$-1.09
PRICE
Prev Close
1.62
Open
1.61
Day Range1.60 – 1.65
1.60
1.65
52W Range1.18 – 2.70
1.18
2.70
31% of range
VOLUME & SIZE
Avg Volume
1.9M
FUNDAMENTALS
P/E Ratio
-1.5x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.98
Market-like
TECHNICAL
RSI (14)
63
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 97 days
Aug 26
AUTL News
About
autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. we are building a leading biotechnology company focussed on the development and commercialisation of engineered t-cell therapies for haematological and solid tumours. autolus has the ambition to be a leader of a revolution in medicine in which life-threatening diseases are treated by a patient’s own cells.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Country
United Kingdom
Website
Martin Pule MBBSFounder, Senior Vice President & Chief Scientific Officer
Alex DriggsSenior Vice President of Legal Affairs & General Counsel and Secretary
Robert F. DolskiSenior Vice President & Chief Financial Officer
Christian Martin ItinChief Executive Officer & Director
Chris WilliamsSenior VP & Chief Business Development Officer
Matthias WillSenior Vice President & Chief Development Officer
Alexander SwanSenior Vice President & Chief Human Resources Officer
Christopher VannSenior Vice President & Chief Operating Officer
Dilip PatelSenior Vice President of Leading Global Pricing & Market Access Srategy
Patrick McIlvennySenior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
Amanda CrayExecutive Director of Investor Relations & External Communications
Miranda NevilleSenior VP & Chief Technology Officer
Olivia ManserDirector of Investor Relations
Vesna CizejSenior Vice President of Strategic Development